Plastic Surgery Hospitals in China Industry Research Report – Now Available from IBISWorld

The relatively young Plastic Surgery Hospital industry in China has been growing at the rapid pace of 16.3% annually over the past five years. In 2012, industry revenue is set to reach $106.3 million. Recent trends in the Plastic Surgery Hospital industry in China include the emergence of the male market for plastic surgery and increased patient concerns regarding the health and safety of procedures. Rising incomes and an aging population will continue to support the industry's development. However, external competition from medical spas will increase, reducing industry profitability, says IBISWorld.

San Francisco, CA (PRWEB) October 28, 2012

The relatively young Plastic Surgery Hospital industry in China has been growing at the rapid pace of 16.3% annually over the past five years. In 2012, industry revenue is set to reach $106.3 million. Rising demand for plastic surgery has been driven by changing attitudes toward self image, technological advancements, higher disposable incomes, and the aging population in China, says IBISWorld.

The top four plastic surgery hospitals, Shanghai Ninth People’s Hospital, Beijing Yezi Plastic and Cosmetic Surgery Hospital, Xijing Hospital, and Second Affiliated Hospital of Nanjing Medical University, account for half of total industry revenue. Major hospitals are concentrated in Shanghai, Jiangsu and Beijing and are equipped with advanced technology, professional academicians and a large number of medical beds for operations. Large and newly developed plastic surgeries can only be performed in these hospitals. In addition to large and reputed hospitals, there are many small hospitals or clinics that can only conduct some traditional low-risk plastic surgeries. These private clinic centers are expected to be acquired by larger hospitals over the next few years.

Recent trends in the Plastic Surgery Hospital industry in China include the emergence of the male market for plastic surgery and increased patient concerns regarding the health and safety of procedures. Micro-plastic or cosmetic injections, such as Botox, are the fastest-growing procedures as they are considered the safest, will the least recovery time and side effects. Rising incomes and an aging population will continue to support the industry's development. However, external competition from medical spas will increase, reducing industry profitability, says IBISWorld.

For more information, visit IBISWorld’s Plastic Surgery Hospitals in China industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Industry Report Key Topics

Plastic Surgery Hospitals in China perform surgical and non-surgical procedures intended to enhance the physical appearance for cosmetic or reconstructive purposes.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772. Reported by PRWeb 12 minutes ago.